TerminatedPhase 4NCT01478035
Study on the Efficacy of Phenytoin in the Prophylaxis of Seizures of Patients With Pneumococcal Meningitis at Least 50 Yrs Old.
Studying Pneumococcal meningitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- M. Carmen Cabellos Minguez
- Principal Investigator
- M. Carmen Cabellos, MDHospital Universitari de Bellvitge
- Intervention
- Phenytoin(drug)
- Enrollment
- 26 target
- Eligibility
- 50 years · All sexes
- Timeline
- 2011 – 2015
Study locations (4)
- Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain
- Hospital Juan Canalejo, A Coruña, Spain
- Fundacio Institut per la Recerca de l'hospital de la Santa Creu i Sant Pau, Barcelona, Spain
- Hospital Virgen del Rocio, Seville, Spain
Collaborators
Hospital Universitari de Bellvitge · Hospital Vall d'Hebron · Germans Trias i Pujol Hospital · Hospital Clinic of Barcelona · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Hospitales Universitarios Virgen del Rocío · Hospital Universitario La Paz · Hospital Universitario Ramon y Cajal · Hospital Juan Canalejo · Hospital Mutua de Terrassa · Hospital Universitario Virgen Macarena
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01478035 on ClinicalTrials.govOther trials for Pneumococcal meningitis
Additional recruiting or active studies for the same condition.